Dr Reddy’s to Bring India’s First CDSCO-Approved Dengue Vaccine QDENGA to Private Market in 2027
CDSCO granted marketing authorisation for Takeda’s tetravalent dengue vaccine in July 2026. The regulator’s official vaccine database lists the dengue tetravalent live attenuated vaccine of Takeda Biopharmaceuticals India among vaccines approved during the year.